110 related articles for article (PubMed ID: 22231769)
1. Response letter to the article: recurrent femur neck fracture and response to bisphosphonates in polyostotic fibrous dysplasia: a novel molecular mechanism.
Namazi H
Indian J Pediatr; 2012 Nov; 79(11):1535; author reply 1535-6. PubMed ID: 22231769
[No Abstract] [Full Text] [Related]
2. Recurrent femur neck fracture and response to bisphosphonates in polyostotic fibrous dysplasia.
Rastogi A; Bhadada SK; Bhansali A
Indian J Pediatr; 2012 May; 79(5):667-9. PubMed ID: 21761121
[TBL] [Abstract][Full Text] [Related]
3. Pamidronate for fibrous dysplasia due to McCune Albright Syndrome.
Kochar IP; Kulkarni KP
Indian Pediatr; 2010 Jul; 47(7):633-5. PubMed ID: 20683120
[No Abstract] [Full Text] [Related]
4. Bisphosphonate therapy for fibrous dysplasia.
DiMeglio LA
Pediatr Endocrinol Rev; 2007 Aug; 4 Suppl 4():440-5. PubMed ID: 17982393
[TBL] [Abstract][Full Text] [Related]
5. Lack of scintigraphic response of fibrous dysplasia to bisphosphonate treatment.
Florez H; Peris P; Vidal-Sicart S; Monegal A; Guañabens N
Rheumatology (Oxford); 2016 Oct; 55(10):1735. PubMed ID: 27411478
[No Abstract] [Full Text] [Related]
6. Pamidronate treatment of polyostotic fibrous dysplasia: failure to prevent expansion of dysplastic lesions during childhood.
Chan B; Zacharin M
J Pediatr Endocrinol Metab; 2006 Jan; 19(1):75-80. PubMed ID: 16509531
[TBL] [Abstract][Full Text] [Related]
7. Estimation of bone strength parameters and response to treatment in McCune-Albright syndrome using peripheral quantitative computed tomography of the tibia.
Atsali E; Zoubos AB; Stathopoulos KD; Stefos E; Bournazos I; Papadimitriou A; Nicolaidou P; Skarantavos G
J Clin Densitom; 2012; 15(4):461-466. PubMed ID: 22819140
[No Abstract] [Full Text] [Related]
8. An extensive hemimelic polyostotic fibrous dysplasia: a case report.
Mrabet D; Rekik S; Sahli H; Ben Amor M; Meddeb N; Sellami S
Rheumatol Int; 2012 Apr; 32(4):1075-8. PubMed ID: 21331571
[TBL] [Abstract][Full Text] [Related]
9. Bisphosphonate treatment of bone fibrous dysplasia in McCune-Albright syndrome.
Lala R; Matarazzo P; Andreo M; Marzari D; Bellone J; Corrias A; de Sanctis C;
J Pediatr Endocrinol Metab; 2006 May; 19 Suppl 2():583-93. PubMed ID: 16789621
[TBL] [Abstract][Full Text] [Related]
10. Alendronate therapy in polyostotic fibrous dysplasia presenting with pathologic fracture.
Jayaraman M; Karikumar K; Verma A; Modi KD
Am J Orthop (Belle Mead NJ); 2011 Mar; 40(3):E48-50. PubMed ID: 21720608
[TBL] [Abstract][Full Text] [Related]
11. Bisphosphonate treatment in polyostotic fibrous dysplasia of the cranium: case report and literature review.
Mansoori LS; Catel CP; Rothman MS
Endocr Pract; 2010; 16(5):851-4. PubMed ID: 20570808
[TBL] [Abstract][Full Text] [Related]
12. Bisphosphonate therapy in polyostotic fibrous dysplasia.
Kumar S
Indian Pediatr; 2004 Oct; 41(10):1069-70. PubMed ID: 15523142
[No Abstract] [Full Text] [Related]
13. Continuous effect with long-term safety in zoledronic acid therapy for polyostotic fibrous dysplasia with severe bone destruction.
Wu D; Ma J; Bao S; Guan H
Rheumatol Int; 2015 Apr; 35(4):767-72. PubMed ID: 25230905
[TBL] [Abstract][Full Text] [Related]
14. Estimation of bone strength parameters and response to treatment using peripheral quantitative computed tomography.
Blake GM
J Clin Densitom; 2012; 15(4):385-386. PubMed ID: 22921770
[No Abstract] [Full Text] [Related]
15. [Albright's fibrous dysplasia. Evolution of a case].
Cigala F; Misasi M
Chir Organi Mov; 1979; 65(5):597-600. PubMed ID: 262884
[No Abstract] [Full Text] [Related]
16. Bone mineral density response to long-term bisphosphonate therapy in fibrous dysplasia.
Parisi MS; Oliveri MB; Mautalen CA
J Clin Densitom; 2001; 4(2):167-72. PubMed ID: 11477309
[TBL] [Abstract][Full Text] [Related]
17. Fibrous dysplasia of the femoral neck. Treatment by cortical bone-grafting.
Enneking WF; Gearen PF
J Bone Joint Surg Am; 1986 Dec; 68(9):1415-22. PubMed ID: 3536935
[TBL] [Abstract][Full Text] [Related]
18. Shepherd's crook deformity with an intracapsular femoral neck fracture in fibrous dysplasia.
Tsuchiya H; Tomita K; Matsumoto T; Watanabe S
Clin Orthop Relat Res; 1995 Jan; (310):160-4. PubMed ID: 7641433
[TBL] [Abstract][Full Text] [Related]
19. [Bisphosphonates in the therapy of fibrous dysplasia. Relevant data and practical aspects].
Egner-Höbarth S; Welkerling H; Windhager R
Orthopade; 2007 Feb; 36(2):124, 126-30. PubMed ID: 17277960
[TBL] [Abstract][Full Text] [Related]
20. [Fibrous dysplasia].
Rödl R; Götze C
Orthopade; 2008 Jan; 37(1):49-55. PubMed ID: 18084739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
